Outlook YouTube Instagram Facebook LinkedIn Google+  Twitter#TRICON  
MMTC15_Header  
MMTC M Header 
Cancer-Channel Icon 

The heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, genomic-based and immune-modulated therapies that are enabling precision oncology.

Cancer Molecular Markers


Circulating Tumor Cells


Cancer Immunotherapy - New


Predictive Preclinical Models in Oncology

 

You may also be interested in:

Symposia:

Circulating Cell-Free DNA

Biomarkers for Cancer Immunotherapy

 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Premier Sponsors:  

Bina Technologies

Cellecta 

Coyote 

Elsevier 

Jackson Laboratory 

 

 NanoString   

 

 Precision for Medicine 

 

Seegene

SeraCare

 

Silicon Biosystems

 

Surrogen 


ThermoFisher Scientific

Thomson Reuters